Please login to the form below

Not currently logged in
Email:
Password:

Samsung Bioepis

This page shows the latest Samsung Bioepis news and features for those working in and with pharma, biotech and healthcare.

Settlement clears path for Biogen, Samsung’s Humira biosimilar

Settlement clears path for Biogen, Samsung’s Humira biosimilar

Biogen and partner Samsung Bioepis have agreed a deal that will allow their biosimilar version of AbbVie’s Humira to launch in Europe and the US. ... The Samsung Bioepis settlement reflects the strength and breadth of AbbVie's intellectual property,

Latest news

More from news
Approximately 15 fully matching, plus 94 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Biosimilars: Getting the flock to market

    Biosimilars: Getting the flock to market. The biosimilars field is about to become very crowded. Here are some Life tips on how to stand out from the herd. Biosimilars have now been with us for over 10 years. In case you haven't been paying

  • Lucid Group make the cut at the PMEAs 2017

    Lucid Group make the cut at the PMEAs 2017. We’ re enormously proud that three of our programmes have made it to the finals at the upcoming Pharmaceutical Marketing Excellence Awards! Jan Steele COO and co-founder commented, “ We are extremely

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics